HYPD
Hyperion DeFi, Inc.NASDAQHealthcare$3.25+1.54%ClosedMarket Cap: $16.2M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.52
P/S
20.25
EV/EBITDA
-2.04
DCF Value
$-1.61
FCF Yield
-366.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.4%
Operating Margin
-2333.4%
Net Margin
-5570.6%
ROE
-130.0%
ROA
-87.5%
ROIC
-38.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $496.2K | $-39.8M | $-6.29 |
| FY 2025 | $813.5K | $-45.3M | $-9.40 |
| Q3 2025 | $302.5K | $6.6M | $1.85 |
| Q2 2025 | $0.00 | $-8.7M | $-10.32 |
Analyst Ratings
View AllChardan CapitalBuy
2026-03-27Trading Activity
Insider Trades
View AllKnox David R.officer: Chief Financial Officer
SellWed Apr 01
Rubenstein Robertofficer
SellMon Jan 12
Rubenstein Robertofficer: General Counsel
SellMon Jan 12
Knox David R.officer: Chief Financial Officer
BuyMon Jan 05
Strahlman Ellen Rdirector
BuyTue Dec 30
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
2.63
A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.